XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 1,267.7 $ 1,360.7
Cash and cash equivalents held at Consolidated Funds 352.3 209.0
Restricted cash 4.5 0.8
Corporate treasury investments 57.3 20.0
Investments, including accrued performance allocations of $6,209.2 million and $7,117.7 million as of September 30, 2023 and December 31, 2022, respectively 9,974.7 10,767.9
Investments of Consolidated Funds 7,059.2 6,894.4
Due from affiliates and other receivables, net 688.3 579.4
Due from affiliates and other receivables of Consolidated Funds, net 131.7 101.9
Fixed assets, net 154.8 139.9
Lease right-of-use assets, net 337.4 337.0
Deposits and other 119.9 78.4
Intangible assets, net 796.0 897.8
Deferred tax assets 13.5 15.8
Total assets 20,957.3 21,403.0 Close
Liabilities and equity    
Debt obligations 2,275.5 2,271.7
Loans payable of Consolidated Funds 6,419.2 5,905.2
Accounts payable, accrued expenses and other liabilities 263.5 369.2
Accrued compensation and benefits 3,694.4 4,320.9
Due to affiliates 290.0 362.5
Deferred revenue 413.8 126.4
Deferred tax liabilities 276.2 402.7
Other liabilities of Consolidated Funds 279.9 279.3
Lease liabilities 496.0 502.9
Accrued giveback obligations 44.0 40.9
Total liabilities 14,452.5 14,581.7 Close
Commitments and contingencies
Common stock, $0.01 par value, 100,000,000,000 shares authorized (360,719,374 and 362,298,650 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively) 3.6 3.6 Close
Additional paid-in-capital 3,337.8 3,138.5
Retained earnings 2,902.6 3,401.1
Accumulated other comprehensive loss (323.9) (322.2)
Non-controlling interests in consolidated entities 584.7 600.3 Close
Total equity 6,504.8 6,821.3 Close
Total liabilities and equity $ 20,957.3 $ 21,403.0